Temozolomide + RT boosts survival in elderly with glioblastoma

CHICAGO – Adding concomitant and adjuvant temozolomide to a shorter course of radiotherapy (RT) for elderly patients with glioblastoma improves progression-free survival, according to a phase III...
Source: Clinical Neurology News - Category: Neurology Source Type: news
More News: Brain | Neurology | Temodar